Cedilla Therapeutics is a private biotechnology company pioneering a new dimension in precision oncology. They are focused on developing novel small molecule therapeutics that conditionally modulate protein stability. Their approach aims to harness the cell's natural protein degradation and stabilization machinery to selectively inhibit or degrade oncogenic drivers. This innovative strategy seeks to create powerful and highly selective medicines for cancers and other diseases with high unmet medical need, potentially addressing targets previously considered undruggable.
The Cambridge headquarters serves as the central hub for Cedilla's research and development activities, strategic operations, and corporate functions.
Located in a modern life sciences complex, the facility likely includes state-of-the-art laboratory spaces for drug discovery and development, alongside collaborative office environments.
As a research-driven biotech, the culture is likely dynamic, innovative, and science-focused, emphasizing collaboration and a commitment to tackling challenging diseases.
Its location in Cambridge provides access to a rich ecosystem of academic institutions, talent, and other biotech companies, fostering collaboration and innovation.
Cedilla Therapeutics is primarily based in the United States, with its research and development centered in its Cambridge, MA headquarters. While direct global offices are not prominent, its collaborations, clinical trial sites (as programs advance), and partnerships may extend internationally to leverage global expertise and patient populations in oncology.
200 Cambridgepark Drive, Suite 3000
Cambridge
MA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Cedilla Therapeutics' leadership includes:
Cedilla Therapeutics has been backed by several prominent investors over the years, including:
Cedilla Therapeutics has strengthened its leadership team with key appointments, particularly enhancing its development and financial strategy capabilities.
Discover the tools Cedilla Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Cedilla Therapeutics likely utilizes common corporate email formats. The most probable format is [first_initial][last]@cedillatx.com.
[first_initial][last]@cedillatx.com
Format
aglucksmann@cedillatx.com
Example
80%
Success rate
Cedilla Therapeutics Website (Press Release) • October 26, 2023
Cedilla Therapeutics announced its participation and presentations at the Stifel 2023 Healthcare Conference and the 35th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, highlighting its ongoing work in developing novel cancer therapies....more
Cedilla Therapeutics Website (Press Release) • May 1, 2023
Cedilla Therapeutics announced the appointment of Karen Tubridy, Pharm.D., as Chief Development Officer. Dr. Tubridy brings over 20 years of experience in global drug development, with a focus on oncology....more
Cedilla Therapeutics Website (Press Release) • April 17, 2023
Cedilla Therapeutics presented preclinical data for its TEAD inhibitor (CTX-4774) and CDK2 inhibitor (CTX-3223) at the American Association for Cancer Research (AACR) Annual Meeting 2023, showcasing their potential in oncology....more
Cedilla Therapeutics Website (Press Release) • January 4, 2023
Cedilla Therapeutics announced the appointment of Justin Renz, J.D., M.B.A., as chief financial officer (CFO) and chief business officer (CBO). Mr. Renz brings nearly 20 years of experience in healthcare finance, strategy, and business development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Cedilla Therapeutics, are just a search away.